16 results
Selected Clinical Trials of SGLT2 inhibitors in CVD and CKD
EMPA-REG OUTCOME - Empagliflozin lowered CV events
and CKD EMPA-REG ... SGLT2i in HF and CKD ... SGLT2i in HF and CKD ... + T2DM; first renal ... visualabstract #table
Summary of dosing recommendations in renal impairment of commonly used hypoglycaemic agents

#Diabetes #Diabetic #Medications #Pharmacology #Dosing
recommendations in renal ... Dosing #Dosing #Renal ... #Impairment #CKD ... #Table #GFR #Hypoglycemics
Adjusted Pain Medication Dosing based on GFR

#Renal #Dosing #Pain #Pharmacology #Opiates #CKD #Gabapentin #Table
based on GFR #Renal ... Pharmacology #Opiates #CKD ... #Gabapentin #Table
Oral Antihypertensive Medications - Selection by Comorbidities
Comorbidities: 
 • Stable Angina, HFpEF, HFrEF, AFib, TAA/Marfan, Aortic
Comorbidities: • Stable ... Dissection • CKD ... , DM, ESRD, PKD ... #pharmacology #table ... #management
Acquired Cystic Kidney Disease (ACKD) Screening and Management
 • Asymptomatic dialysis/renal transplant patient, aged >60 years,
Kidney Disease (ACKD ... Screening and Management ... Asymptomatic dialysis/renal ... lumbar pain, fever, erythrocytosis ... Kidney #Disease #ACKD
Diabetes Medications Summary Table
Insulin
Lifestyle modifications
Metformin
Sulfonylureas
GLP-1 receptor agonists - ↓ major adverse CV events
TZDs
DPP-4 inhibitors
SGLT2 inhibitors -
Medications Summary Table ... Improved outcomes in CKD ... #medications #table ... #comparison #management
Intern Pocket Cards - Pharmacologic Pain Management Options
Anti-inflammatory:
 • Acetaminophen (24 hours: < 3-4g in healthy
Pharmacologic Pain Management ... adults, <3g in CKD ... avoid NSAIDs if CKD ... Equianalgesia Conversion Table ... Opioid #Conversion #Table
Staphylococcus-associated GlomeruloNephritis - Diagnosis and Management Summary
CLINICAL
 • Nephritic syndrome (Casts)
 • Marked proteinuria (may be
Diagnosis and Management ... • Often severe renal ... available • Renal ... - Pivotal in management ... Follow-up: • CKD
Immunosuppression in Transplantation
Induction (I):
 - Basiliximab (Simulect)
 - Alemtuzumab (Campath)
 - Rituximab
 - Anti-Thymocyte Globulin (ATG)
Induction
- Mycophenolic Acid ... #Pharmacology #Table ... #Maintenance #Management ... #Nephrology #Renal
Causes of Secondary Hypertension - Workup and Differential Diagnosis
Approach (when evaluation should be done):
1. Severe or
with previously stable ... eg, presence of renal ... • Vascular: Renal ... Renal parenchymal ... disease: CKD, acute